Not a Defence of Organ Markets
Journal of Practical Ethics 7 (3):54-66 (2019)
Abstract
Selgelid and Koplin’s article ‘Kidney Sales and the Burden of Proof’ (K&S 2019) presents a series of detailed and persuasive arguments, intended to demolish my own arguments against the prohibition of organ selling. And perhaps they might succeed, if the case described by the authors were anything like the one I actually make. However, notwithstanding the extensive quotations and the detailed explanations of the way I supposedly argue, this account of my position comprehensively mistakes both the conclusions I reach and the arguments I give for them. I know that there are around many misconceptions about my views on this subject, but I have always hoped they could not survive a reading of what I had actually written. I have just—after a gap of many years—looked again at the two most recent of the texts Koplin and Selgelid refer to, and it goes without saying that I can see various things I could now do better; but I do still find these misinterpretations hard to understand. And since anyone with nothing to go on but this article would reasonably conclude that the original texts were not worth reading, I am grateful to the editors for the opportunity to try to set the record straight. I presume not many readers would be interested in a detailed comparative commentary on the texts, showing where this account gets my intentions wrong. I shall try instead to explain how what I do mean—and what I think I say—diverges from what is said here, and then go on to a brief outline of what my arguments and conclusions really are. I hope this may also give some sense of why, for all the opposition I have encountered since I was first drawn into this debate, I persist in thinking that the work I have been doing is important not only for this topic but for analysis in practical ethics more generally.Author's Profile
My notes
Similar books and articles
Kidney Sales and the Burden of Proof.Julian Koplin & Michael Selgelid - 2019 - Journal of Practical Ethics 7 (3):32-53.
From blood donation to kidney sales: the gift relationship and transplant commercialism.Julian J. Koplin - 2015 - Monash Bioethics Review 33 (2-3):102-122.
Beyond Fair Benefits: Reconsidering Exploitation Arguments Against Organ Markets.Julian J. Koplin - 2018 - Health Care Analysis 26 (1):33-47.
Kidney Sales and Market Regulation: A Reply to Semrau.J. Koplin Julian - 2017 - Journal of Medicine and Philosophy 42 (6):653-669.
Assessing the Likely Harms to Kidney Vendors in Regulated Organ Markets.Julian Koplin - 2014 - American Journal of Bioethics 14 (10):7-18.
Will you give my kidney back? Organ restitution in living-related kidney transplantation: ethical analyses.Eisuke Nakazawa, Keiichiro Yamamoto, Aru Akabayashi, Margie H. Shaw, Richard A. Demme & Akira Akabayashi - 2020 - Journal of Medical Ethics 46 (2):144-150.
A liver for a kidney: Ethics of trans-organ paired exchange.Emond J. Samstein B., de Melo-Martin I., Kapur S., Ratner L. - 2018 - American Journal of Transplantation 18 (5):1077-1082.
If you can’t sell your kidney, can you trade it? Examining the morality of alternative kidney exchange institutions.Stephen Schmidt - manuscript
Iranian kidney market in limbo: a commentary on “The ambiguous lessons of the Iranian model of paid living kidney donation”.Hojjat Soofi - 2016 - Monash Bioethics Review 34 (2):148-151.
Just love in live organ donation.Kristin Zeiler - 2009 - Medicine, Health Care and Philosophy 12 (3):323-331.
Reassessing the Likely Harms to Kidney Vendors in Regulated Organ Markets.Luke Semrau - 2017 - Journal of Medicine and Philosophy 42 (6):634-652.
Autonomy, Moral Constraints, and Markets in Kidneys.S. J. Kerstein - 2009 - Journal of Medicine and Philosophy 34 (6):573-585.
Commentary. An ethical market in human organs.J. Radcliffe Richards - 2003 - Journal of Medical Ethics 29 (3):139-140.
Analytics
Added to PP
2020-02-06
Downloads
84 (#147,118)
6 months
13 (#73,154)
2020-02-06
Downloads
84 (#147,118)
6 months
13 (#73,154)
Historical graph of downloads